Atypical glandular cells of undetermined significance in cervical cytologic findings

American Journal of Obstetrics and Gynecology

Volumn 180, Issue 4, 1999, Pages 883-888

  Manetta, Alberto ^a,b   Keefe, Kristin ^a   Lin, Fritz ^a   Ahdoot, David ^a   Kaleb, Vanessa ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Bldg 23 ^*  (United States)

Author keywords

Atypical cells; Atypical glandular cells of undetermined significance; Papanicolaou smear

Indexed keywords

ADOLESCENT; ADULT; AGED; ANAMNESIS; CANCER GRADING; CLASSIFICATION; COLPOSCOPY; CONFERENCE PAPER; CURETTAGE; DIAGNOSTIC APPROACH ROUTE; ENDOMETRIUM BIOPSY; FEMALE; FOLLOW UP; GYNECOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

EID: 0032904013     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70659-9     Document Type: Conference Paper

References (16)

1. 1. National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. JAMA 1989:262:931-4.
2. 2. Kennedy AW, Salmier SS, Wirth SL, Biscotti CV, Tuason LJ, Travarca MJ. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGUS) Detected on cervical cytology screening. Gynecol Oncol 1996;63:14-8.
3. 3. Bottles K, Reiter RC, Steiner AL, Zaleski S, Bedrossian CWM, Johnson SR. Problems encountered with the Bethesda system: the University of Iowa experience. Obstet Gynecol 1991;78: 410-4.
4. 4. Goff BA, Atanasoff P, Brown E, Muntz HG, Bell DA, Rice LW. Endocervical glandular atypia in Papanicolaou smears. Obstet Gynecol 1992;79:101-4.
5. 5. Taylor RR, Guerrieri JP. Nash JD, Henry MR, O'Connor DM. Atypical cervical cytology: colposcopic follow-up using the Bethesda system. J Reprod Med 1993;38:448-7.
6. 6. Zweizig S, Noller K, Reale F, Collis S, Resseguie L. Neoplasia associated with atypical glandular cells of undetermined significance on cervical cytology. Gynecol Oncol 1997;65:314-8.
7. 7. Duska LR, Flynn CF, Chen A, Whall-Strojwas D, Goodman A. Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology. Obstet Gynecol 1998;91:278-82.
8. 8. Lin F, Ghafari S, DiSaia PJ. An analysis of atypical squamous cells in cervicovaginal cytology [abstract]. Acta Cytol 1995;39:979.
9. 9. Korn AP, Judson PL, Zaloudek CJ. Importance of atypical glandular cells of uncertain significance in cervical cytologic smears. J Reprod Med 1998;43:774-8.
10. 10. Boone ME, Baak JP, Kurver JPH, Overdiep H, Verdonk GW. Adenocarcinoma in situ of the cervix: an underdiagnosed lesion. Cancer 1981;48:768-73.
11. 11. Trevino FM, Moyer ME, Valdez RB, Stoup-Benham CA. Health insurance coverage and utilization of health services by Mexican-Americans, mainland Puerto Ricans, and Cuban Americans. JAMA 1991:265:233-7.
12. 12. Centers for Disease Control and Prevention. Chronic disease in minority populations. Atlanta: The Centers; 1994.
13. 13. Wright TC, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995;85:202-10.
14. 14. Marcus AC, Crane LA, Kaplan CP, Reading AE, Savage E, Gunning J, et al. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategics. Med Care 1992;30:216-29.
15. 15. Carey P, Gjerdingen DK. Follow-up of abnormal Papanicolaou smears among women of different races. J Fam Pract 1993;37:583-7.
16. 16. Burger RA, Monk BJ, Van Nostrand KM, Greep N, Anton-Culver H, Manetta A. Single visit program for cervical cancer prevention in a high-risk population. Obstet Gynecol 1995;86:491-8.